While the pembrolizumab copy was eye-catching, the firm’s next big biosimilar launch in Europe is a version of Roche’s Herceptin (trastuzumab). Biosimilar companies are poised to launch ...

The FDA has approved Amgen and Allergan’s biosimilar of Roche’s Herceptin, just in time for the breast cancer blockbuster’s patent expiry. Herceptin’s main US patent expires this month ...

The Herceptin Biosimilar Market Size was estimated at 4.38 (USD Billion) in 2024. The Herceptin Biosimilar Market Industry is expected to grow from 4.81 (USD Billion) in 2025 to 11.12 (USD Billion ...

Aurobindo Pharma's biosimilar for breast cancer recommended for EU approval, demonstrating similarity to Herceptin.

Hyderabad: CuraTeQ Biologics s.r.o., a wholly owned step-down subsidiary of Aurobindo Pharma Limited, has announced that the ...

HLX02 exemplifies the desire of Henlius to expand globally. This biosimilar version of Herceptin (trastuzumab) was the first Chinese-developed, off-patent biologic to be approved for study in ...

Anne Steele covers the music industry for The Wall Street Journal's entertainment bureau in Los Angeles. She was previously a ...

By the late ’90s, a drug called Herceptin that targeted the HER2 receptor, sped into the clinic on ... Lab safety rules dictate that one must tie back long hair. Rosemarie Hansen learned the hard way ...